In this article, we will take a look at the fifteen largest ophthalmology companies in the world. If you want to see more companies in this selection, go to the 5 Largest Ophthalmology Companies on the planet .

The ophthalmology industry encompasses the diagnosis, treatment, and prevention of eye disorders and diseases. This includes medical and surgical treatments, as well as the manufacturing and distribution of products such as eyeglasses, contact lenses, plus ophthalmic instruments. The industry also includes optometry, which is the particular branch of healthcare that deals with the examination, diagnosis, and therapy of visual disorders. Ophthalmologists and optometrists are the particular primary practitioners with this field, and they work in a variety of settings, including private practices, hospitals, and clinics. The particular outlook for the ophthalmology industry is generally positive, with growth expected in the coming years. The ophthalmology business has staged a recovery from the depression in 2020 due to COVID-19-related restrictions plus lockdowns.

The particular size associated with the global ophthalmology business is expected to compound at an average rate of 6. 52% to $81. 05 billion within 2027. Furthermore, according in order to the data released by the World Health Organization (WHO) in October 2022, nearly 2. 2 billion people around the world have near or far vision impairment. Out of these 2 . 2 billion people, eyesight impairment-related problems could either have been avoided or even addressed for one billion dollars people. By 2050, half of the world’s population, or 4. 8 billion , is anticipated to be myopic.

The bright outlook of the ophthalmology market can be attributed to several factors. Firstly, as the worldwide population ages, the incidence of age-related eye diseases like cataracts and age-related macular degeneration (AMD) is likely to increase, driving demand for ophthalmology services and products. Secondly, the prevalence of vision diseases such as diabetic retinopathy and glaucoma is also expected to increase, particularly in developing countries, due to factors such as diabetes plus hypertension. In addition, the development of new technologies, this kind of as laser-based treatments and minimally invasive surgical techniques, is anticipated to drive growth in the particular ophthalmology market. Finally, the increasing availability of healthcare in building countries can also be expected in order to drive development within the ophthalmology market, because more individuals will possess access to attention care services. Some of the largest ophthalmology businesses in the world include Novartis AG (SWX: NOVN), Johnson & Johnson Vision, and Alcon Inc. (NYSE: ALC ).

Photo by Ozkan Guner on Unsplash

Our Methodology

We first conducted thorough research from the ophthalmology industry to identify the largest ophthalmology companies in the particular world after analyzing their drug pipelines, revenue, market share, and overall size. All of us then chose 15 biggest of these companies.   While some of these companies are pure-play ophthalmology firms specializing in ophthalmic drug solutions or even equipment, others have well-established ophthalmology divisions  as the part associated with their health care unit. These divisions generate a substantial amount of annual revenue, justifying the companies’ inclusion in our list. These companies have been ranked in ascending order of their revenue posted within 2021.

Biggest Ophthalmology Businesses in the World

15. Nidek Co., Ltd.

2021 Revenue: $162. 4 million

Nidek Company., Ltd. is a Gamagori, Aichi Prefecture, Japan-based company established in 1971 that specializes in developing, production, and distributing diagnostic plus therapeutic equipment for ophthalmology. The company offers a wide range associated with products with regard to various ophthalmic conditions such as cataracts, glaucoma, and retinal disorders.

Nidek Co., Ltd. employs 1, 641 professionals plus operates overseas subsidiaries in China, the US, India, Singapore, Brazil, and Korea. Nidek Co., Ltd. ’s product portfolio includes diagnostic devices such since fundus cameras, optical coherence tomography (OCT) systems, plus automated perimetry devices. The company also offers therapeutic gear such as YAG laser systems, excimer laser systems, and femtosecond laser techniques for cataract surgery and other refractive procedures. Nidek Co., Limited. is known for its advanced technology plus innovative items.

14. STAAR Surgical Company (NASDAQ: STAA )

2021 Revenue: $230. 5 mil

STAAR Surgical Company (NASDAQ: STAA) is really a Monrovia, California-based company that will specializes within the formulation, manufacture, and distribution of ophthalmic products, particularly intraocular lenses (IOLs) and related delivery systems.

STAAR Medical Company (NASDAQ: STAA) offers a wide range of items for various ophthalmic conditions for example cataracts and presbyopia. The company’s product portfolio includes an implantable Collamer lens (ICL) for that treatment of myopia, hyperopia, plus astigmatism and the EVO Visian ICL, a foldable lens that will be inserted into the eye’s posterior chamber. STAAR Surgical Company (NASDAQ: STAA) also have a range of IOLs for cataract surgery, such as the AcrySof IQ Toric IOL and AcrySof IQ ReSTOR IOL, that is designed in order to reduce the need for glasses after cataract surgery.

13. Glaukos Corp ( NYSE: GKOS )

2021 Revenue: $294. 01 million

Glaukos Corp (NYSE: GKOS) is the San Clemente, California-based medical technology organization founded in 1998 that focuses on the particular creation and manufacture associated with glaucoma remedies. Glaucoma is usually a disease that causes damage to the optic nerve and can lead to blindness if left untreated.

Glaukos Corp’s (NYSE: GKOS) primary focus is to develop minimally invasive glaucoma surgery (MIGS) products that will lower intraocular pressure (IOP) in patients with glaucoma and ocular hypertension. The company has developed iStent, the particular first and only FDA-approved MIGS device for your treatment of open-angle glaucoma. iStent is definitely a tiny device that is placed within the eye to help improve the outflow associated with fluid and reduce IOP. Glaukos Corp (NYSE: GKOS) furthermore develops plus markets other MIGS devices such because iStent inject and Cypass micro-stent.

12. Lumenis

2021 Revenue: $425 mil

Lumenis can be a Yokneam, Israel-based healthcare device business founded in 1991 that specializes within developing and manufacturing laser beam and light-based technologies regarding ophthalmology, aesthetic, and surgical applications.

The particular ophthalmology products offered by Lumenis include laserlight systems intended for cataract plus glaucoma surgery, as well as photocoagulation systems to get retinal problems. The organization also offers products for laser-assisted in situ keratomileusis (LASIK) surgery and other refractive procedures. Lumenis is known for its innovative and advanced technology in the industry of ophthalmology. The company is focused on providing minimally-invasive treatment pertaining to the ophthalmology and visual market. Lumenis has over 220 registered patents plus multiple FDA clearances because of its products as of 2023.

11. Topcon Healthcare

2021 Revenue: $1. 06 billion

Topcon Healthcare is a Tokyo, Japan-based medical device company that is the subsidiary of TOPCON CORPORATION (TYO: 7732), a precision measurement techniques and technologies company.

The product profile of Topcon Healthcare consists of diagnostic tools such as fundus cameras, optical coherence tomography (OCT) systems, and automated perimetry gadgets. The business furthermore provides therapeutic equipment this kind of as YAG laser techniques, excimer laser systems, and femtosecond laser beam systems meant for refractive methods. Recently, the company developed the Topcon Triton, a laser system for the treatment associated with glaucoma, plus the Topcon KR-8000PW, a digital retinal camera. Topcon Health care is a renowned producer of digital phoropters and automatic lensmeters as well.

10. Carl Zeiss Meditec AG (ETR: AFX)

2021 Income: $2. 07 billion dollars

Carl Zeiss Meditec AG is 59% owned simply by Oberkochen, Germany-based Carl Zeiss AG and is also a member of the TecDAX listed firm on the particular German stock exchange. The company is a manufacturer of optic systems, industrial measurements, plus medical devices, including ophthalmic equipment.

Carl Zeiss Meditec AG’s ophthalmology division offers a wide range of items for eyesight examinations, which includes slit lamps, fundus digital cameras, and refractors. The corporation also provides medical equipment such as microscopes and intraocular lenses. Carl Zeiss Meditec AG is famous for the high-quality precision products and the diverse variety of optical biometers, ophthalmic surgical microscopes, Humphrey Perimeters, and information management tools in its portfolio. The company posted $2. 07 billion within revenue in 2021, making it one associated with the biggest ophthalmology businesses in the world.

9. Santen Pharmaceutical Co Ltd (TYO: 4536)

2021 Revenue: $2. 35 billion

Santen Pharmaceutical is a good Osaka, Japan-based ophthalmic-focused pharmaceutical company founded in 1890. The company develops and markets prescription ophthalmic products in order to treat eyes disorders.

Santen Pharmaceutical’s item portfolio contains treatments designed for glaucoma, retinal disorders, dry eye disease, and allergic conjunctivitis. Santen’s lead product is an eye drop called EYLEA (aflibercept), which is used to treat wet age-related macular degeneration and diabetic retinopathy. The company also has a wide range of products for glaucoma treatment, like Taflotan, the prostaglandin analog, and Sant-GLA, a Rho kinase inhibitor. Santen Pharmaceutical’s products are available in many countries worldwide, as well as the company is certainly continuously investing in R& D for brand new treatments just for ophthalmological illnesses. The organization sells its products within 50 nations.

8. AbbVie Inc (NYSE: ABBV )

2021 Revenue: $2. 4 billion

AbbVie Inc (NYSE: ABBV) is a Chicago, Illinois-based healthcare company. The business has its own ophthalmology division involved in the production of medications that treat various vision diseases. AbbVie Inc (NYSE: ABBV) also offers a pipeline of investigational drugs related to the therapy of retinal vein occlusion and diabetic macular edema. The company is renowned for establishing medications in order to manage or treat ocular surface illness, glaucoma, retinal disease, plus presbyopia. AbbVie Inc (NYSE: ABBV) bought Allergan in May 2020 to develop and progressively broaden the revenue stream with new therapeutic spheres.

Baron Funds shared its outlook upon AbbVie Inc (NYSE: ABBV) in the Q3 2022 investor letter. Here’s what the firm said:

“AbbVie Incorporation.   (NYSE: ABBV) is a drug developer best known for Humira, an immunosuppressant that will is the particular best selling medication of all time. Given outsized key product risk (patent cliff and generic launches beginning in 2023), AbbVie has broadened its pipeline, highlighted by the Allergan acquisition. Shares fell on results that missed consensus and indications that will legacy franchises were outperforming newer product launches, calling into question AbbVie’s long-term strategy. With promising assets in the pipeline plus its robust cash flow profile, we believe AbbVie will grow well in to the future. ”

7. CooperVision

2021 Revenue: $2. 93 billion

CooperVision is the San Ramon, California-based manufacturer of contact lenses with a presence within over 100 countries.

The company produces a wide range of contact zoom lens products with regard to various vision correction needs, including spherical, toric, multifocal, and colored lenses. These types of products aid in treating numerous widely recognized conditions like myopia, hyperopia, astigmatism, and presbyopia. The particular company also offers daily disposable, two-week replacement, and monthly replacement disposable lenses. CooperVision is well known for its advanced lens technologies plus commitment to providing comfortable, healthy, and effective get in touch with lens options for its customers. CooperVision is focused on providing effective plus visually satisfying contact zoom lens wear through its study and development of sophisticated lens designs and materials.

6. Bausch + Lomb

2021 Income: $3. 77 billion dollars

Bausch + Lomb will be an Ontario, Canada-based attention care, consumer health care, surgical, and pharmaceutical organization with a rich history of almost 170 years. The organization evolves, manufactures, plus markets a wide variety of ophthalmic surgical products and musical instruments, eye care products, and pharmaceuticals.

The company is best identified for the contact lenses, lens treatment products, and ophthalmic surgical devices. A few of the company’s most popular products include the Bausch & Lomb ULTRA contact lens and the Bausch & Lomb SofPort intraocular lenses. They also have got an array of medical instruments, this kind of as the particular Stellaris Elite Vision Enhancement System plus the Stellaris PC Eyesight Enhancement System, which are used for cataract and retinal surgery.

Miller Value Partners shared its outlook on Bausch Health Companies Inc. (NYSE: BHC) in its Q2 2022 investor letter. Here’s what the firm said:

Bausch  Health  Companies  Inc.   (NYSE: BHC)  declined during the quarter as the particular company consummated its Bausch+Lomb IPO in valuations far below expectations, reported disappointing Q1 2022 results, and delayed its plan to spin out the Solta (aesthetics) business because of to difficult market problems. While the company spun off 10% of Bausch+Lomb (BCLO) they retained 90% of the business which they intend to distribute once these people have met their target leverage ratio of six. 5-6. 7x. The future spin-off value of the particular Bausch+Lomb piece represents a value of $12. 55 per share, 39% above where Bausch Health is currently trading. The business recently appointed John Paulsen as Chair of the Board, which should accelerate value realization. ”

In addition to Bausch + Lomb, Novartis AG (SWX: NOVN), Johnson & Manley Vision, plus Alcon Incorporation. (NYSE: ALC) are furthermore some of the largest ophthalmology companies on the planet.

Click in order to continue reading and observe the 5 Largest Ophthalmology Companies within the World .

Suggested articles:

Disclosure: None. 15 Largest Ophthalmology Businesses on earth   is usually originally published on Insider Monkey.

Leave a Reply

Your email address will not be published. Required fields are marked *